Determination of antigen components in inactivated SARS-CoV-2 vaccine using ultra-high-performance liquid chromatography tandem mass spectrometry | Synapse
March 3, 2026
Determination of antigen components in inactivated SARS-CoV-2 vaccine using ultra-high-performance liquid chromatography tandem mass spectrometry
Key Points
The analysis reveals key antigen components of the inactivated SARS-CoV-2 vaccine, enhancing understanding of immune responses.
Using ultra-high-performance liquid chromatography tandem mass spectrometry, specific components were accurately identified.
The research highlights the importance of identifying antigen profiles for effective vaccine development and optimization.
These findings may lead to improved vaccine formulations and effectiveness in combating COVID-19.